Wolfram syndrome is the association of diabetes mellitus and optic atrophy, also called DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy and deafness). Incomplete characterisation has caused diagnostic confusion; we therefore undertook a nation wide cross-sectional case finding study. We identified 45 patients with Wolfram syndrome, median age 29 years.
Optic atrophy and diabetes mellitus were described in four siblings by Wolfram and Wagener in 1938 , and have been taken as essential features of Wolfram syndrome. 1 The acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness) has been used synonymously with Wol fram syndrome to indicate two other complications commonly found. In a literature review, diabetes mellitus and optic atrophy were consistently present, diabetes insipidus and deafness were present in 51 % of cases, and all four complications present in 13%. 2 Despite extensive literature reviews, 2-4 the syndrome is poorly understood. In particular, the natural history of the optic atrophy, its site of pathology and the pathogenesis are all unclear.
In Wolfram's original description, the two eldest siblings developed poor vision at 6 and 8 years respectively, and when examined 10 years later, acuity was reduced to counting fingers. Case reports of the syndrome have contained too few patients to make generalisations; literature reviews have not clarified whether the optic atrophy is preceded by a period of normal vision or is always progressive and, if so, over what time period.
There has been confusion over the site of pathology in the visual pathway: in a series of 7 patients, one was found to have pigmentary retinal dystrophy. 5 A later review of electroretinographic (ERG) findings in 19 patients concluded that the visual disorder was mainly due to a lesion in the ganglion cell and nerve fibre layer. 6 Eleven further patients had normal ERGs but abnormal visual evoked potentials, suggesting that the retina is not involved in the pathogenesis? A postmortem study of one patient revealed atrophy, severe axonal destruction and demyelination of the optic nerve, chiasm, tract and radiations, and shrunken nerve cells in reduced numbers in the superior colliculus and lateral geniculate body. 8 The inheritance of Wolfram syndrome is thought to be autosomal recessive, and a nuclear-encoded gene has recently been mapped to chromosome 4p. lO,l1 However, the presence of pigmentary retinal dystrophy in at least some patients together with other complications commonly seen in mitochondrial disorders (deafness, optic atrophy, diabetes mellitus, ataxia) led to suggestions that some cases might be due to mitochondrial gene abnormalities. 12 We recently undertook a nationwide cross-sec tional case finding study to characterise Wolfram syndrome Y In this present paper we aim to describe the ophthalmic complications of our cohort of patients, and provide accurate data on the natural history, site of pathology and pathogenesis of optic atrophy.
METHODS
Patients were recruited nationally from major referral centres and a national DIDMOAD register that had been set up under the auspices of the British Diabetic Association. Minimum ascertainment cri teria for identification of patients were juvenile onset diabetes mellitus (under 30 years) and optic atrophy, which were chosen as the only features consistently present and earliest to develop in 166 of 168 case reports. 4 The two main referral sources were all consultant ophthalmologists and physicians.
All living patients were visited at home for clinical history taking and examination; hospital records were also studied. All affected patients had been examined, with pupils dilated, by experienced ophthalmologists; the results of these examinations, and information on visual acuity, colour vision testing, examination of visual fields, ERGs, and visual evoked potentials (VEP), were obtained wherever possible from hospital records. Cranial MRI scans were also available for some patients.
Visual function tests were performed in some patients at Birmingham and Midland Eye Hospital. The 2 Hz transient VEPs were recorded to flash and reversing black and white chequerboard patterns, recorded monocularly using a two-channel montage. Pattern ERGs were recorded using a 6 Hz reversing black and white chequerboard, and gold foil electro des.
A polymerase chain reaction (PCR) Apa1 restric tion site assay was used to screen for the mitochon drial tRNA Leu (UUR) A to G (3243) mutation. 14 The final cycle of PCR was labelled with 33 p_dATP, permitting detection of the mutation at levels of heteroplasmy below 1%. Mitochondrial DNA was also analysed for the presence of major rearrange ments by a standard method: 15 PCRs were per formed in a final volume of 50 /-LI with 0.25 /-LI each of primers L1 (nt2695-2720) and H3 (nt16459-16436), 2.5 mM MgCh, 0.25 mM of each dNTP, 1 x Bio Optiform 111 buffer (Bioline) and 1.5 units Bio-X ACT Taq polymerase (Bioline). PCRs were hot started at 80°C by the addition of 20-50 ng DNA and denatured at 95°C for 10 seconds, and 68 °c for 10 minutes plus 30 seconds for each subsequent cycle (25 cycles). PCR products were run on 0.7% Seakem agarose gels.
RESULTS
Fifty-four patients were referred with the minimum ascertainment criteria of juvenile onset diabetes mellitus and optic atrophy. Nine patients were excluded: 2 had congenital rubella syndrome, 1 had Leber's hereditary optic neuropathy, 16 4 had thia mine-responsive megaloblastic anaemia with dia betes and deafness (thiamine-responsive anaemia syndrome), and 2 were unclassified (one had retinal dystrophy and diabetes mellitus; the other presented at 14 months with ketoacidotic coma, hypoxia and seizures, and then secondary optic atrophy and anterior pituitary failure).
The remaining 45 patients were classified as having Wolfram syndrome. There were 29 index patients (14 male, 15 female) and 16 secondary patients (all siblings; 7 male and 9 female). Thirty-five patients were alive during the study (median age 29 years, range 5-46 years). Thirty-six patients presented with diabetes mellitus, 6 with optic atrophy, and 3 with diabetes insipidus. No patient presented with deaf ness.
The clinical features of this cohort have been described, 13 and are summarised in Table I . The ascertainment criteria were validated by comparison of index with secondary patients as shown in Table I . All secondary patients also had diabetes mellitus and optic atrophy; there was no significant difference in the ages of onset or prevalence of complications between the two groups (p>0.02). Generalised optic atrophy was observed in all patients at a median age of 11 years (range 6 weeks to 19 years), and was the presenting feature of Wolfram syndrome in only 2 patients. The presenting symptoms were decreasing visual acuity and loss of colour vision, patients typically complaining that everything was going grey.
In 42 patients there was a documented period of normal vision before optic atrophy became sympto- matico Out of these 42 patients, 24 had documented progression to a visual acuity of 6/60 or less in the better eye over a median of 8 years (range 1-25 years). One 28-year-old patient had a rapid onset of decreasing visual acuity over weeks aged 15 years, to 6/24 in the better eye, and no progression since then; this patient has diabetes mellitus and optic atrophy only. Thirty-four patients were registered blind, and 7 patients partially sighted. Most of the patients registered as blind had residual vision allowing perception of light and dark, human shapes or a hand in front of the face. Two unrelated girls, aged 15 and 17 years, had visual acuities of 6/18 biaterally, diabetes mellitus, and no other complications.
The remaining 3 patients (of 45) presented in infancy and were diagnosed as having congenital optic atrophy. Two of these 3 are brothers, aged 16 and 18 years respectively, and have a non-progres sive optic atrophy and diabetes mellitus only.
Colour vision was mentioned in the records of 22 patients: the commonest defect was blue-yellow, the Farnsworth error scores for 2 patients being grossly abnormal at 844 and 914 respectively.
Visual fields were recorded for 15 patients before the onset of severely reduced acuity; they consis tently showed bilateral paracentral scotomas, with some peripheral constriction in 5 patients.
Absent pupillary responses to light were found in all 11 patients with acuities less than 6/60 who were tested. Nine of these patients also had horizontal nystagmus; these were older patients with other cerebellar signs induding ataxia and dysarthria.
Three patients had evidence of cataract formation. No pigmentary retinal dystrophy was seen on ophthalmoscopy. Five patients had definite evidence of background diabetic retinopathy out of 34 for whom a recent ophthalmic examination was recorded; the median duration of diabetes mellitus in these 5 patients was 33 years (range 20-36 years), compared with the median duration in the whole cohort of 24 years (range 2-44 years).
Visual evoked responses were abnormal in all 10 patients tested, typically showing no responses to flash or pattern stimulation. ERGs were undertaken in 6 patients. Three of these were normal; in 3 there was a reduction in amplitude of response without significant change in latency. Cranial MRI showed abnormalities in 8 of 11 patients: the commonest finding was a generalised atrophy, particularly of the brainstem and cerebel lum. In addition there was reduced signal from the optic nerves, chiasm and tracts. The brain of one patient was available for postmortem study: this clearly showed macroscopic atrophy of the optic nerves and chiasm (Fig. 2) .
Eighteen patients were screened for the mitochon drial tRNA Leu (3243) mutation; all screened negative. In addition, no major mitochondrial re arrangements were found in DNA extracted from whole blood of 40 patients.
CASE HISTORY
A previously well girl presented with insulin-depen dent diabetes mellitus at 4 years of age. Her older brother had been diagnosed with Wolfram syndrome aged 6 years; consequently she was referred to an ophthalmologist who found bilateral optic atrophy, reduced visual acuity (6/18 bilaterally) and poor colour vision. Cranial CT scan was normal, as was ultrasound of her renal outflow tracts. She continued to have thirst and polyuria despite good glycaemic control, and a raised serum sodium (148 mmolll).
Cranial diabetes insipidus was diagnosed, and she responded to intranasal Desmopressin spray (Ferring). At 7 years she was seen at the Birmingham and Midland Eye Hospital. Her visual acuity had deterio rated to 6/60 bilaterally, and she had a marked afferent pupillary defect, with a refractive error +2.S in both eyes. Visual field testing revealed bilateral centrocecal scotomas, worse in the right eye. The Farnsworth 100 Hue test showed a gross tritanopic defect binocularly, with an error score of 392 (normal <100). Fundoscopy confirmed bilateral optic atrophy, with normal retinal vessels. An audiogram showed a high tone loss greater than SO dB above 2000 Hz. Visual evoked responses were of PNP waveform (neg) in both eyes. Pattern responses were markedly delayed in both eyes, with reduced amplitude froin the right eye. Pattern ERGs showed a normal PSO (preganglionic) component; the N9S 14 (ganglion cell component) was absent from the right eye and grossly reduced in the left eye.
Over the next year she developed unsteadiness with occasional falls. On examination she had mild intention tremor of her hands, with an ataxic gait but no nystagmus. Cranial MRI showed reduced signal from the optic nerves.
DISCUSSION
We have shown that the visual defect in Wolfram syndrome is a progressive optic atrophy, with a median age of onset of 11 years; this leads to perception of light and dark only, over a median of 8 years. Electrophysiology, cranial imaging and post mortem examination all point to the site of pathology as the optic nerve; this appears to be the first manifestation of a more generalised neurodegenera tion. We have found no evidence of an underlying mitochondrial genome mutation or rearrangement.
A limiting factor of the study was the spread of patients across the country; thus visual function tests could not all be performed in one centre. Results of electrophysiological testing from patients outside the West Midlands NHS region have therefore been extracted from hospital records.
The ascertainment criteria and natural history of Wolfram syndrome have already been discussed P Diabetes mellitus and optic atrophy are the best available diagnostic criteria as they were present in all affected siblings of index patients. Patients present with diabetes mellitus and optic atrophy in the first decade, cranial diabetes insipidus and sensorineural deafness in the second, dilated renal tracts in the third, and multiple neurological abnormalities in the fourth decade, particularly cerebellar ataxia, dysarthria and startle myoclonus. Eight of 11 male patients had biochemical evidence of primary gonadal atrophy. Premature death may occur from respiratory failure associated with brain stem atrophy. This is a primary neurodegenerative disease process presenting with the unusual combi nation of diabetes mellitus and optic atrophy. The differential diagnosis includes other causes of neuro degeneration.
The median age of onset of optic atrophy of 11 years is in general agreement with the results of other studies, which range from 8 years 2 to 13 years P It is usually preceded by a period of normal vision, as most patients in the UK would have had their vision tested at school entry. In this condition most have developed insulin-dependent diabetes mellitus by the time optic atrophy is diagnosed, and have to cope for many decades with a combination of handicaps not usually experienced by individuals with isolated diabetes mellitus.
The presenting features of reduced visual acuity not due to a refractive error and colour vision defect suggest a site of pathology in the visual pathway proximal (posterior) to the eye. Blue-green colour vision loss is a recognised feature of optic nerve atrophy.
The rate of progression of visual loss shows a wide variability (1-25 years), but distinguishes Wolfram syndrome from more acute causes of vision loss such as Leber's hereditary optic neuropathy (weeks/ T. G. BARRETT ET AL. months). We found one patient with an acute onset then non-progression, and 3 patients with apparent non-progressive, congenital optic atrophy. It is unclear whether this clinical heterogeneity represents the involvement of several different genes or the variable manifestations of a single pleiomorphic gene.
The involvement of both the central and periph eral visual fields in patients investigated with perimetry, is in agreement with the findings of Neimeyer and Marquardt 6 and again points to a site of pathology in the visual pathway proximal to the retina.
Absent pupillary responses to light were found in patients with the most severe vision loss. This finding is more likely to be related to an afferent system disorder or underlying generalised neurodegenera tion than a complication of diabetes mellitus. Patients with diabetic autonomic neuropathy would be expected to have severe small vessel disease, which was not seen in this cohort. The horizontal nystag mus is also probably related to the underlying neurodegeneration as it was seen in patients with other cerebellar signs.
It is surprising that only 5 patients had background diabetic retinopathy; the median duration of diabetes mellitus of these 5 patients was 33 years, compared with the median duration of diabetes mellitus in the whole cohort of 24 years. This suggests that Wolfram patients eventually develop diabetic retinopathy but that the rate of progression is slower than in type 1 diabetics. It has been suggested that 90% of a popUlation of conventionally treated type 1 diabetics would be expected to develop retinopathy after 20 years. 1S All Wolfram patients required insulin, were insulin deficient, and had relatively poor glycaemic control as assessed by glycated haemoglobin mea surements. Our finding cannot be explained by the higher mortality in Wolfram syndrome compared with type 1 diabetics, as many of the Wolfram cohort patients have survived long enough to develop retinopathy. Retinal vessel attenuation secondary to optic atrophy could conceivably protect the retina from hypertension and glucose toxicity. 19 Retinal vessel abnormalities associated with optic atrophy usually require a direct retinal insult such as retinal dystrophy; in optic atrophy due to damage to the retrolaminar optic neve (as in Wolfram syndrome), retinal vessels are unaffected, z° Animal studies have shown that diabetes-induced increases in vascular permeability in retinal vessels are prevented by castration; 21 our finding of reduced levels of sex hormones in Wolfram patients with primary gonadal atrophy may indicate a hormonal modulation of the development of diabetic retinopathy. 13 Alternatively there may be a direct gene effect. Conditions in diabetics known to be associated with reduced prevalence of diabetic retinopathy include carotid stenosis, glaucoma and high myopia. 22 To this list should be added Wolfram syndrome.
The electrophysiological tests confirm previous work 7 suggesting that the pathogenesis of the optic atrophy does not lie in the retina, but primarily affects the optic nerve. The absent visual evoked responses to flash and pattern stimulation, together with colour blindness, indicate a probable optic nerve pathology. Reduced ERG responses in 3 of 6 patients is compatible with another report of retinal function in Wolfram syndrome: 6 the authors found slight reduction in ERG responses in 2 patients, not accounted for by diabetic retinopathy, which was absent. The ERG changes could not account for the profound reduction in visual function. The authors concluded that the ganglion cell and optic nerve fibre layer were predominantly affected, and hypothesised that retrograde trans synaptic degeneration may be responsible for involvement of the ganglion cell layer.
Cranial MRI scans in our patients confirm previous reports of reduced signals from the sites of the optic nerves, 9 and demonstrate the wider under lying neurodegeneration seen in this syndrome. This is demonstrated most vividly in the macroscopic appearance of the undersurface of the brain of a patient with Wolfram syndrome (Fig. 2) : atrophy of the optic nerves, chiasm and tracts is part of a wider atrophy that includes the medulla and pons, cere bellum and vermis.
Wolfram syndrome shares some clinical character istics with disorders of the mitochondrial genome, which mediate their effects through disruption of the respiratory chain enzymes and energy production in the form of ATP. Shared clinical features include diabetes mellitus, deafness, optic atrophy, ataxia and myoclonus. However, we have found no evidence of a mitochondrial genome mutation or rearrangement in this cohort of patients. It may be that Wolfram syndrome is caused by a nuclear-encoded energy supply defect -either underproduction or inefficient use of ATP, perhaps in maintaining membrane integrity. Our recent improved localisation of a Wolfram syndrome gene to chromosome 4p ll should permit identification of the gene product and better understanding of this disorder.
